Infectious disease research is a demanding field for molecular imaging analysis. Molecular imaging of pathogens requires analysis at the organism level, to determine the distribution of pathogens throughout the body, as well as at the cellular level, to examine the detailed mechanisms of infection and immune response [1] [2] [3] . Present technologies have allowed for in vivo tracking of pathogens in live animals using bioluminescence and visualization of involved molecules using fluorescent staining with appropriate antibodies, but these techniques were employed separately [4, 5] . In many cases, particularly for newly identified highrisk pathogens, appropriate antibodies do not exist [6, 7] . Furthermore, antibody-based immunostaining cannot be applied to tracing studies imaging live animals or cells. Owing to these problems, studies on the in vivo mechanisms of several pathogens have proved difficult in comparison with those of well-characterized diseases like cancer [8] [9] [10] . The pathogenesis of infectious diseases is complex, involving various virulent factors and immune molecules, and varies over time in different organs, tissue, and cell types [11, 12] . To accurately analyze in vivo infection mechanisms, the pathogenesis needs to be spatiotemporally analyzed simultaneously at the organism, organ, tissue, and cell levels.
Burkholderia pseudomallei is a gram-negative and high-risk pathogen in humans. Infection leads to melioidosis, a severe infectious disease [13, 14] . As it is pathogenic at low doses, B. pseudomallei could be used as a biological weapon [15] . Efficient vaccines and treatments remain undeveloped and these should be based on the molecular mechanisms of pathogenesis, which requires information about pathogen distribution and immune responses of infected hosts [16, 17] . In this study, we have produced B. pseudomallei H0901-M2GFP-Lux, which emits luminescence for non-invasive pathogen tracking in the host, and fluorescence for tissue and single-cell imaging to provide basic information of B. pseudomallei infection.
The Institutional Animal Care and Use Committee of the Korea Centers for Disease Control and Prevention (KCDC) approved the animal studies. Female 6-week-old BALB/c mice were purchased from Orient Bio (Korea) and intravenously challenged with 1 × 10 7 or 1 × 10 8 colony forming units (CFU)/ml of B. pseudomallei H0901-M2GFP-Lux. Bioluminescence images were acquired and analyzed using an IVIS Lumina III device (PerkinElmer, USA). Before imaging, the mice were anesthetized with 2-3% isoflurane in an oxygen-filled isolation chamber. Bioluminescence was quantified using Living Image Software (PerkinElmer). Frozen tissue sections were prepared as previously described [1] . J774A.1 cells (1 × 10 4 cells/ml), grown in Dulbecco's modified Eagle's medium (DMEM), were infected with bacteria at a multiplicity of infection (MOI) of 10 for 2 h in a 4-well chamber slide (Nunc, USA). After infection, the cells were washed 3 times with phosphatebuffered saline (PBS) containing 100 µg/ml ceftazidime and 800 µg/ml kanamycin, incubated with DMEM containing 50 µg/ml ceftazidime for 2 h at 37ºC, washed with PBS, and fixed with 2.5% paraformaldehyde. After washing, the samples were mounted onto chamber slides with the nucleic acid dye 4',6'-diamino-2-phenylindole (Invitrogen, USA), overlaid with a cover glass, and sealed. Fluorescent images were obtained using a confocal microscope (FV1000; Olympus, Japan) and analyzed with Olympus Software (FluoView ver. 2.0). Statistical analyses were performed using GraphPad Prism 6 software (GraphPad Software, USA). Mean values ± standard deviations were determined from triplicate samples. Multiple comparisons were made by one-way analysis of variance (ANOVA) followed by Tukey's post hoc test.
B. pseudomallei H0901 was isolated from a melioidosis patient in Korea [18] and was used to generate H0901-M2GFP-Lux using pT7-M2GFP-Lux (Fig. 1A) . All experiments using B. pseudomallei H0901 and its derivatives were performed at biosafety level 3, in accordance with the guidelines of the KCDC.
B. pseudomallei H0901-M2GFP-Lux was constructed by transforming the plasmid pT7-M2GFP-Lux into B. pseudomallei H0901. The genes for M2GFP, an enhanced form of green fluorescent protein (GFP) [19] , and the lux operon for luciferase expression were amplified from the pTOPO-M2GFP-Lux using the primers EcoRI-F and EcoRI-R ( Table 1 ). The PCR product was cloned into the pBHR1 plasmid (MoBiTec GmbH, Germany) to produce pT7-M2GFP-Lux (Fig. 1A, Table 1 ). pTOPO-M2GFP-Lux was constructed by inserting the genes for M2GFP and the lux operon from pKK214-GFP [19] and pXen12 (Caliper Life Science, USA), respectively. B. pseudomallei H0901-M2GFP-Lux constitutively expressed obvious fluorescent and luminescent signals compared with wild-type B. pseudomallei, and the relative signals increased with the bacterial dose. Average radiance intensities of H0901-M2GFP-Lux were increased with increased bacteria count on the patch plates (Fig. 1B) .
As for in vivo imaging at the organism level, bioluminescence was detected in both posterior and ventral views of BALB/c mice infected with B. pseudomallei H0901-M2GFP-Lux (Fig. 2A) . With the increase of infection dose, bioluminescence signals increased significantly compared with the PBS control (Fig. 2B) . For organ levels, B. pseudomallei H0901-M2GFP-Lux was intravenously injected, and bioluminescence, normalized to the bacterial load, was quantified in mouse organs by ex vivo imaging. Although H0901-M2GFP-Lux was located in multiple organs, the bacterial dissemination in the lung, liver, and spleen was drastically increased compared with the PBS control in the pathogen tracking images using luminescence signals (Fig. 3A, left panel) . For tissue levels, fluorescent confocal microscopic analyses were used to demonstrate bacterially infected spleen tissues in the mice. The dissemination and growth of B. pseudomallei H0901-M2GFP-Lux was observed in the spleen throughout the observation period (Fig. 3A, right panel) . Six hours after infection, almost all liver, spleen, and lung tissues emitted fluorescence (data not shown). For observation at cellular levels, murine macrophage J774A.1 cells were infected with B. pseudomallei H0901-M2GFP-Lux at an MOI of 10. After 2 h, B. pseudomallei infection was observed in the cytoplasm using the fluorescent confocal microscope (Fig. 3B) . Intracellular survival of H0901-M2GFP-Lux increased over the total 4 h time course (data not shown). These results indicate that B. pseudomallei H0901-M2GFP-Lux can be used for in vivo imaging for spatiotemporal information at the organism, organ, tissue, and cell levels of the host simultaneously.
In conclusion, molecular imaging using a dual-labeled bacterial strain provides an efficient method to study infection processes of the host. Pathogens can be traced simultaneously in live organisms, organs, tissues, and cells without pathogen-specific antibodies, providing detailed information on the pathogenesis and immune responses. The application of our analysis method using dual-labeled bacteria is not restricted to B. pseudomallei, but can be expanded to many pathogens. The pathogens can be visualized and traced by substituting the appropriate replication origin and promoter of pT7-M2GFP-Lux. Furthermore, as our dual-labeling method is highly sensitive, it could also be used for the detection and analysis of lowcopy bacteria.
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